A Comparison of Enteric-Coated Aspirin Granules with Plain and Buffered Aspirin: A Report of Two Studies

Petroski, Donald
January 1986
American Journal of Gastroenterology;Jan1986, Vol. 81 Issue 1, p26
Academic Journal
Reported herein are two endoscopic studies performed to compare the gastrointestinal mucosal effects of encapsulated enteric-coated aspirin granules with several other well-known aspirin products. The first study compared the effects of Ascriptin A/D, Bayer, Bufferin, and 325 mg enteric-coated aspirin granules (325 mg Ecotrin capsules); the second study compared Anacin Arthritis Pain Formula, Arthritis Strength Bufferin, Ascriptin A/D, Bayer, and 500 mg enteric-coated aspirin granules (500 mg Ecotrin capsule). In both of these studies the Ecotrin capsule induced less stomach damage than did any of the other aspirin products tested. The Ecotrin capsule was also shown to cause less damage to the proximal duodenum than did Bayer.


Related Articles

  • Preventing stroke and MI with coated aspirin. P.F.C. // Cortlandt Forum;03/25/98, Vol. 11 Issue 3, p128 

    Focuses on the optimal dose of enteric-coated aspirin in the prevention of stroke and myocardial infarction. Mechanism of the coated aspirin.

  • Pharmacokinetic Study and Trial for Preparation of Enteric-Coated Capsule Containing Insulinomimetic Vanadyl Compounds: Implications for Clinical Use. Sakurai, Hiromu; Fugono, Jun; Yasui, Hiroyuki // Mini Reviews in Medicinal Chemistry;Jan2004, Vol. 4 Issue 1, p41 

    To treat patients suffering from diabetes mellitus, we developed several types of orally active vanadyl complexes to replace painful insulin injections, and prepared them in the form of enteric-coated capsules containing vanadium compounds. Pharmacokinetic analysis demonstrated that these...

  • FORMULATION AND EVALUATION OF MODIFIED RELEASE CAPSULES OF LANSOPRASOLE. Chandira, Margaret; Sharma, Ankit; Bhowmik, D.; Jayakar, B. // Pharma Research;2010, Issue 4, p61 

    Immediate release dosage form of Lansoprazole results rapid dissolution and rapid rise in plasma drug concentration within a short period after administration. Subsequently due to metabolism and elimination the plasma drug concentration falls below the therapeutic level. Thus require a modified...

  • Lavage to Remove Enteric-Coated Aspirin and Gastric Outlet Obstruction. Sogge, Merle R.; Griffith, John I.; Sinar, Dennis R.; Mayles, George R. // Annals of Internal Medicine;Dec77, Vol. 87 Issue 6, p721 

    Presents a case study related to the accumulation of intact enteric-coated aspirin in the stomach secondary to gastric outlet obstruction. Evaluation of the efficiency of gastric lavage in the removal of aspirin; Medical history of the patient with duodenal ulcer disease; Standard techniques to...

  • One-Step Aqueous Enteric Coating Systems. Cunningham, Charles R.; Fegely, Kurt A. // Pharmaceutical Technology Europe;Oct2001, Vol. 13 Issue 10, p48 

    Evaluates two enteric coating systems for coating performance on acetylsalicylic acid tablets. Characteristics of tablets used in functional coating; Description of the mixing process used; Examination of the coating process under study.

  • A Comparative Single-Dose Bioequivalence Study of Two Enteric Coated Aspirin Brands Among Healthy Volunteers. Zeitoun, Abeer A.; Dib, Jean G.; Mroueh, Mohammad // Journal of Applied Research;Summer2003, Vol. 3 Issue 3, p242 

    Objective: Aspicot® is an enteric-coated aspirin that is being extensively used in the Middle East, including Lebanon where this drug is manufactured, without any clinical in vivo implication showing or confirming its bioequivalence. For this reason, this investigation was carried out to...

  • NEW RP-HPLC METHOD DEVELOPMENT AND VALIDATION DETERMINATION FOR ESTIMATION OF DULOXETINE HCL IN ENTERIC COATED CAPSULES. Boopathy, D.; Jawarkar, Rahul Dadaroji; Prakash, M.; Mathew, Bibin; Perumal, P. // International Journal of ChemTech Research;Jan2010, Vol. 2 Issue 1, p239 

    A simple, selective, rapid, and precise reverse phase HPLC method has been developed for the simultaneous estimation of duloxetine HCL in enteric coated capsules. An X Terra RP, C-8 column (4.6x150mm) was used for the separation. The mobile phase was acetonitrile: phosphate buffer (65:35%v/v)...

  • Aspirin resistance and enteric coating. Elliott, William T. // OB/GYN Clinical Alert;Feb2013 Pharmacology Watch, p2 

    The article discusses the correlation between enteric coated aspirin and aspirin resistance.

  • COLONIC DRUG DELIVERY SYSTEM OF TRIMETAZIDINE HYDROCHLORIDE FOR ANGINA PECTORIS. Kumar, S. N. Anil; Pavanveena, Chitagunta; Kavitha, K. // International Journal of Pharmacy & Pharmaceutical Sciences;Apr2011, Vol. 3 Issue 2, p22 

    The aim of the present study is to develop colon targeted drug delivery systems for Trimetazidine Hcl using Chitosan as a carrier. In this study, investigation of an oral colon specific, pulsatile device to achieve time or site specific release of Trimetazidine, based on chronopharmaceutical...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics